¼¼°èÀÇ Ã¼¿Ü µ¶¼º ½ÃÇè ½ÃÀå º¸°í¼­ : µ¿Çâ, ¿¹Ãø ¹× °æÀï ºÐ¼®(-2030³â)
In-Vitro Toxicology Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
»óǰÄÚµå : 1417532
¸®¼­Ä¡»ç : Lucintel
¹ßÇàÀÏ : 2024³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 - page report
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,850 £Ü 5,354,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,467,000
PDF (2 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 2¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,350 £Ü 7,440,000
PDF (5 Users License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,050 £Ü 9,805,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ ±â¾÷ ³» ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÀÌ¿ë Àοø¿¡ Á¦ÇÑÀº ¾øÀ¸³ª, ±¹³»¿¡ ÀÖ´Â »ç¾÷À常 ÇØ´çµÇ¸ç, ÇØ¿Ü ÁöÁ¡ µîÀº Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù. PDF ÆÄÀÏÀº DRM(µðÁöÅÐ ÀúÀÛ±Ç °ü¸® ½Ã½ºÅÛ)ÀÌ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ü¿Ü µ¶¼º ½ÃÇè µ¿Çâ ¹× Àü¸Á

¼¼°è ü¿Ü µ¶¼º ½ÃÇè ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö 9.3%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 2030³â±îÁö ¾à 188¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ¸ÂÃãÇü ÀÇ·á ¹× ½Å¾à °³¹ßÀ» À§ÇÑ ½ÃÇè°ü ³» ±â¼ú¿¡ ´ëÇÑ °ü½É Áõ°¡, µ¿¹° ½ÇÇè¿¡ ´ëÇÑ »çȸÀû ¹Ý´ë Áõ°¡, Á¶±â µ¶¼º °ËÃâÀ» À§ÇÑ ¿¬±¸ °³¹ß ³ë·Â µîÀÔ´Ï´Ù. ¼¼°è ½ÃÇè°ü ³» µ¶¼º Å×½ºÆ® ½ÃÀåÀÇ ¹Ì·¡´Â Á¦¾à »ê¾÷, È­Àåǰ ¹× »ýȰ¿ëǰ, Çмú ±â°ü ¹× ¿¬±¸¼Ò, Áø´Ü, È­ÇÐ »ê¾÷, ½Äǰ »ê¾÷¿¡¼­ ±âȸ°¡ ÀÖÀ» °ÍÀ¸·Î Àü¸ÁµÇ°í ÀÖ½À´Ï´Ù.

in vitro µ¶¼º ½ÃÇè ½ÃÀå ÀλçÀÌÆ®

LucintelÀº ¿¹Ãø ±â°£ µ¿¾È Àü½Å µ¶¼ºÇÐÀÌ °¡Àå Å« ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â Ä¡·á ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±Ý Áö¿ø Áõ°¡, ÇコÄɾî ÁöÃâ Áõ°¡, Á¤±³ÇÑ ÀÎÇÁ¶ó¿Í ½Å¾à °³¹ß ¹× ½ÂÀÎ ÀýÂ÷ÀÇ ¿¬±¸ °³¹ß ¹× ½ÂÀÎÀ» À§ÇÑ °­·ÂÇÑ ±ÔÁ¦ ȯ°æÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ±Ô¸ð°¡ Å« Áö¿ªÀ¸·Î ³²À» °ÍÀÔ´Ï´Ù.

ÀÚÁÖ ¹¯´Â Áú¹®

Q1. ½ÃÀå ±Ô¸ð´Â?

A1. ¼¼°è ü¿Ü µ¶¼º ½ÃÇè ½ÃÀåÀº 2030³â±îÁö ¾à 188¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q2. ½ÃÀå ¼ºÀå Àü¸ÁÀº?

A2. ¼¼°è ü¿Ü µ¶¼º ½ÃÇè ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 9.3%ÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q3. ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?

A3.ÀÌ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀº ¸ÂÃãÇü ÀÇ·á ¹× ½Å¾à °³¹ßÀ» À§ÇÑ Ã¼¿Ü ±â¼ú¿¡ ´ëÇÑ °ü½É Áõ°¡, µ¿¹° ½ÇÇè¿¡ ´ëÇÑ »çȸÀû ¹Ý´ë Áõ°¡, ¿¬±¸°³¹ßÀ» ÅëÇÑ Á¶±â µ¶¼º °ËÃâ¿¡ ´ëÇÑ ³ë·ÂÀÔ´Ï´Ù.

Q4. ½ÃÀåÀÇ ÁÖ¿ä ºÎ¹®Àº?

A4. ¼¼°è ü¿Ü µ¶¼º ½ÃÇè ½ÃÀåÀÇ ¹Ì·¡´Â Á¦¾à»ê¾÷, È­Àåǰ ¹× »ýȰ¿ëǰ, Çмú±â°ü ¹× ¿¬±¸¼Ò, Áø´Ü, È­Çлê¾÷, ½Äǰ»ê¾÷¿¡¼­ À¯¸ÁÇÑ ±âȸ°¡ ÀÖÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Q5. ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº?

A5. ÁÖ¿äü¿Ü µ¶¼º ½ÃÇè ½ÃÀå ±â¾÷Àº ´ÙÀ½°ú °°½À´Ï´Ù.

Q6. ÇâÈÄ °¡Àå Å« ½ÃÀå ºÎ¹®Àº?

A6.LucintelÀº ¿¹Ãø ±â°£ µ¿¾È Àü½Å µ¶¼ºÇÐÀÌ °¡Àå Å« ºÎ¹®À¸·Î ³²À» °ÍÀ¸·Î ¿¹»óÇϰí ÀÖ½À´Ï´Ù.

Q7. ÇâÈÄ 5³â°£ °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â Áö¿ªÀº?

A7. ºÏ¹Ì´Â Ä¡·á ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±Ý Áõ°¡, ÇコÄɾî ÁöÃâ Áõ°¡, Á¤±³ÇÑ ÀÎÇÁ¶ó¿Í ½Å¾à °³¹ß ¹× ½ÂÀÎ ÀýÂ÷¸¦ À§ÇÑ ¿¬±¸°³¹ß ¹× °­·ÂÇÑ ±ÔÁ¦ ȯ°æÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ±Ô¸ð°¡ Å« Áö¿ªÀ¸·Î ³²À» °ÍÀÔ´Ï´Ù.

Q8. º¸°í¼­ Ä¿½ºÅ͸¶ÀÌ¡ÀÌ °¡´ÉÇѰ¡?

A8. ³×. LucintelÀº Ãß°¡ ºñ¿ë¾øÀÌ 10%ÀÇ »ç¿ëÀÚ Á¤ÀǸ¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ Ã¼¿Ü µ¶¼º ½ÃÇè ½ÃÀå : ½ÃÀå ¿ªÇÐ

Á¦3Àå ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®(2018-2030³â)

Á¦4Àå Áö¿ªº° ½ÃÀå µ¿Çâ°ú ¿¹Ãø ºÐ¼®(2018-2023³â)

Á¦5Àå °æÀï ºÐ¼®

Á¦6Àå ¼ºÀå ±âȸ¿Í Àü·«Àû ºÐ¼®

Á¦7Àå À¯·Â ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

In-Vitro Toxicology Testing Trends and Forecast

The future of the global in-vitro toxicology testing market looks promising with opportunities in the pharmaceutical industry, cosmetics & household product, academic institutes & research laboratories, diagnostic, chemicals industry, and food industry. The global in-vitro toxicology testing market is expected to reach an estimated $18.8 billion by 2030 with a CAGR of 9.3% from 2024 to 2030. The major drivers for this market are increasing attention to in vitro techniques for customized medicine and drug discovery, growing public opposition to animal experimentation, and work on early-stage toxicity detection through research and development.

A more than 150-page report is developed to help in your business decisions.

In-Vitro Toxicology Testing by Segment

The study includes a forecast for the global in-vitro toxicology testing by method, technology, application, end use, and region.

In-Vitro Toxicology Testing Market by Method [Shipment Analysis by Value from 2018 to 2030]:

In-Vitro Toxicology Testing Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

In-Vitro Toxicology Testing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

In-Vitro Toxicology Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

In-Vitro Toxicology Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

List of In-Vitro Toxicology Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies in-vitro toxicology testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in-vitro toxicology testing companies profiled in this report include-

In-Vitro Toxicology Testing Market Insights

Lucintel forecasts that systemic toxicology will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period due to the rise in government funding for therapeutic research, the rise in healthcare spending, the development of sophisticated infrastructure and drug discovery procedures, and the robust regulatory environment for approval.

Features of the Global In-Vitro Toxicology Testing Market

Market Size Estimates: In-vitro toxicology testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: In-vitro toxicology testing market size by various segments, such as by method, technology, application, end use, and region in terms of value ($B).

Regional Analysis: In-vitro toxicology testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different method, technology, application, end use, and regions for the in-vitro toxicology testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the in-vitro toxicology testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the in-vitro toxicology testing market size?

Answer: The global in-vitro toxicology testing market is expected to reach an estimated $18.8 billion by 2030.

Q2. What is the growth forecast for in-vitro toxicology testing market?

Answer: The global in-vitro toxicology testing market is expected to grow with a CAGR of 9.3% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the in-vitro toxicology testing market?

Answer: The major drivers for this market are increasing attention to in vitro techniques for customized medicine and drug discovery, growing public opposition to animal experimentation, and work on early-stage toxicity detection through research and development.

Q4. What are the major segments for in-vitro toxicology testing market?

Answer: The future of the global in-vitro toxicology testing market looks promising with opportunities in the pharmaceutical industry, cosmetics & household product, academic institutes & research laboratories, diagnostic, chemicals industry, and food industry.

Q5. Who are the key in-vitro toxicology testing market companies?

Answer: The major drivers for this market are increasing attention to in vitro techniques for customized medicine and drug discovery, growing public opposition to animal experimentation, and work on early-stage toxicity detection through research and development.

Q6. Which in-vitro toxicology testing market segment will be the largest in future?

Answer: Lucintel forecasts that systemic toxicology will remain the largest segment over the forecast period.

Q7. In in-vitro toxicology testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the rise in government funding for therapeutic research, the rise in healthcare spending, the development of sophisticated infrastructure and drug discovery procedures, and the robust regulatory environment for approval.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Global In-Vitro Toxicology Testing Market : Market Dynamics

3. Market Trends and Forecast Analysis from 2018 to 2030

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

5. Competitor Analysis

6. Growth Opportunities and Strategic Analysis

7. Company Profiles of Leading Players

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â